Objective: As of 2017, the pathobiology of gastric cancer (GC) is far from fully understood; consequently, new methods of basic and advanced research have been proposed and tested. The presence (GL1) vs absence (GL0) of malignant cells exfoliated in gastric lavage (GL) of GC patients was formerly evaluated with diagnostic intent but not for staging or prognostic assessment. We investigated this hitherto unreported application of cytopathology.
diagnosed with early GC (EGC), subsequently treated using an endoscopic approach and destined to a favourable prognosis, in the rest of the world, this tumour is still detected at late stages and associated with high mortality (723 000 global deaths in 2012). 1, 2 In addition to the lack of screening, unfavourable outcomes are likely to reflect the limited current knowledge of the pathogenesis and pathobiology of this disease as well as the high degree of clinical heterogeneity of patients suffering from the same stage of disease.
Consequently, researchers have been investigating GC at different levels using basic clinical and molecular oncology studies, and among these studies, amelioration of the present staging systems represents a common and notable effort. [2] [3] [4] [5] Currently, there is a long list of new interesting prognostic factors pending validation. [6] [7] [8] In the present study, we elected to use gastric lavage (GL) of GC patients as the starting point for scientific assessment. Considering the scarcity of pertinent literature, we verified whether cytopathological analysis of GL could lead to scientific progress in terms of clinicopathological, staging and prognostic knowledge and therapeutic implication.
| MATERIALS AND METHODS

| Nasogastric intubation
Between April 2012 and September 2016, 80 patients with a preoperative histology of gastric adenocarcinoma were recruited for this prospective observational study in compliance with the principles embodied in the Declaration of Helsinki. Informed consent was obtained prior to enrolment; 38 subjects were included in a previous study on GC. 9 All participants were fitted with a nasogastric (NG) tube during their hospital stay at the Division of General and Emergency Surgery of St Andrea Hospital, Faculty of Medicine and Psychology, "Sapienza" University, Rome, Italy. In 71 cases, the NG device was inserted at the beginning of intervention prior to tumour manipulation, as palliative care in eight cases and prior to endoscopic submucosal dissection (ESD) of EGC in one case.
| GL: the procedure
The stomach cavity was flushed through the NG pipe with 500 mL of a saline solution: considering its distensible nature, we reasoned that this cut-off value was sufficient to bathe the inner surface of the entire viscus and improve the feasibility of collecting cancer cells, irrespective of the tumour gastric site. Obstructing cardial carcinomas (Siewert type I, II and III) and gastric stump cancers represented sole exceptions to this general rule; in such cases, we adopted a minimum quantity of 250 mL. Asepsis was maintained during the entire procedure using sterile gloves and containers to minimise fungal and bacterial contamination, which could interfere with subsequent cytological examination. All GLs were performed and immediately transported (within a few minutes) to the Cytology Department of our hospital by the same operator (E.V.) to avoid sampling errors and time-dependent alterations. , seven patients with inoperable GC were managed using palliative gastroenterostomy (two cases) and nutritional Witzel jejunostomy (five cases), and one patient was subjected to neoadjuvant treatment following exploratory laparoscopy. At histology, the surgical margins showed infiltration in seven cases (11%). A total of eight patients were non-surgical; among these individuals, seven subjects with late GC were provided with palliative care through a nasoduodenal tube (six cases) or oesophageal stent (one case), whereas one EGC patient underwent ESD at endoscopy. As for cancer grade, eight patients had well-differentiated carcinomas (G1), 10 patients had moderately differentiated carcinomas (G2), 52 patients had poorly differentiated carcinomas (G3) and 10 patients had undifferentiated carcinomas (G4 
| Cytopathology
The cytological examination of GL demonstrated the presence and absence of cancer cells (GL1 vs GL0) in 36 (45%) and 44 (55%) .0024, .003 and .0028; Table 1 ). Notably, as for lymph node metastasis classification, GL1 patients showed a significant relative risk of having N+ rather than N0 (P=.0099).
| Survival
After an overall follow-up of 53 months, 51 patients died: 47 cancer-related deaths and four fatal perioperative complications. Among the 27 male deaths, 14 cases were GL1 (51.85%), whereas among the 24 female deaths, 11 cases were GL1 (45.83%). Altogether, 49%
of deaths (25 subjects Figure 2D ). In the tumour depth subgroup analyses, there was no significant difference in OS between GL1 and GL0 patients in relation to T2, T3, T4 and T3-T4. By con- 
| DISCUSSION
The aim of the present study was to characterise GC cytopathology.
In the case of GC, if the knowledge and utility of cytologically analysing peritoneal lavage is well known, then little information exists with respect to intragastric exfoliation. [13] [14] [15] Traditionally, cytological analysis of GL from GC patients is employed with diagnostic intent. [16] [17] [18] Such an application has been gradually replaced by the combination of upper gastrointestinal endoscopy and biopsy, reflecting their diagnostic superiority in terms of sensitivity and specificity (approximately 100%). 19, 20 As a consequence, no previous studies have considered GL as source of inedited information on pathobiology, management and surveillance of GC. Initially, we assessed the results of a cytological analysis of GL as a new investigable clinicopathological feature of GC. Second, we examined the correlation of GL with other well-known oncological parameters of GC. Finally, we examined the prognostic nature of GL. The results of a previous provisional analysis of GL in 38 GC patients were interesting and promising, prompting us to pursue this research direction. 9, 21, 22 Compared to this analysis, this study not only confirmed some of the previous findings but also provided novel evidence. Among the former, the prospective observational nature, safety, simplicity and low costs of the GL procedure were observed in the present study, and positive cytology (GL1) was significantly correlated with advanced tumour depth (T3-T4) and loco-regional lymph node metastases (N+). 9 Among the latter, in addition to T3-T4 and N+ cancers (P=.0317 and 0.0024, respectively), GL1 was also correlated with the parameters of distant metastases (M1; P=.003) and angiolymphatic invasion (LVI1; P=.0028): these data strongly indicated Values in bold are statistically significant.
GL1 as parameter of an aggressive tumour phenotype, thereby corroborating a previously published hypothesis concerning intragastric cell exfoliation as the sixth metastatic route attended by GC (Figure 3) . 9, 21, 23 We believed that GC cells, after acquiring a metastatic phenotype with the ability to move off and break away from their original tumour, could follow one of the five traditional metastatic pathways (ie, direct infiltration, vascular invasion, lymphatic metastasis, transcelomatic spread and mesogastric dissemination) or dive into the gastric lumen. 21, 23 Specific integrins, cell adhesion molecules and other microenvironmental signals developed by malignant cells themselves, could probably condition each of the final six destinations. 24, 25 However, different from classic metastatic berths, intragastric cells do not cause any metastasis to the enteric tract through natural peristaltic propulsion, which expels them from the anus with faeces. Thus, the endoluminal pathway should be considered to be a mirror of the other five traditional spread patterns; hence, if malignant cells are detected in the gastric lumen (ie, GL1), it is likely that other promoted cells have concomitantly pursued a more classic and truly metastatic route. 9, 21 Furthermore, the present study provided the first demonstration of the prognostic significance of GL1. Indeed, univariate and, more importantly, multivariate analyses revealed that GL1 was the only independent factor predictive of poor prognosis in F I G U R E 2 Kaplan-Meier curves of overall survival rate (OS), progression-free survival (PFS), time to tumour progression (TTP) and diseasefree survival (DFS) for GL1 and GL0 patients. Time in months 26 On the other hand, subjects with advanced GL1 stages could benefit from chemotherapeutic agents and therapeutic schedules, timing and duration, different from GL0 cases.
| CONCLUSION
In summary, we have elucidated an innovative cytological analysis of GL in GC patients: our proposed classification showed that, differently from GL0, GL1 was correlated with advanced disease (larger tumour depth, presence of lymph node metastasis), indicating aggressive tumour behaviour (paralleling LVI1) and a poorer prognosis. In clinical practice, the GL0/GL1 classification should be used for better staging of GC patients, more accurate prognostic stratification and, most importantly, more precise treatment selection, even at early stages of disease. We encourage other authors to conduct this type of investigation: long-term surveillance of wider patient populations could lead to safer conclusions and appropriate applications.
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